A number of investigators have attempted to utilize the hemagglutination system for detection of streptococcal type-specific antibody in human sera. C-ross-reactions have made the procedure unreliable without cumbersome and time-consuming manipulation of the test sera. A method is described in which a microtiter indirect hemagglutination technique, using sensitized sheep erythrocytes, is sensitive, specific, and reliable for titration of type-specific antibody after naturally acquired or induced streptococcal infection.
The role of group A streptococcus M antigens in virulence and the production of protective antibodies in man is well documented (6, 11) . Several types of procedures have been reported for the identification of the type-specific antibody, including the mouse protection (2, 8) , bactericidal (5, 10, 13) , long chain (14) , and hemagglutination tests (1, 3y 12, 16) . The bactericidal reaction has been considered the most reliable test for determining type-specific antibodies for group A streptococci in human sera (6). However, the bactericidal and mouse protection tests have the disadvantages of being time-consuming and cumbersome, whereas the long chain procedure is less sensitive than other methods. The hemagglutination procedure is particularly sensitive, relatively easy to perform, and lends itself better than the others to the examination of large numbers of specimens. However, the hemagglutination techniques described to date have had the disadvantage of extensive cross-reactions. Although these cross-reactions have been removed by adsorption of the test sera, this added manipulation has limited the practicability of the method.
This report describes a microtiter indirect hemagglutination technique which is characterized by a high degree of sensitivity, the requirement of a small volume of patients' serum and reagents, and minimal nonspecific reactions. The procedure has been valuable in measuring host immunological response following known streptococcal infections by various group A serotypes.
MATERIALS AND METHODS
Organisms. Specific serotypes of group A streptococci isolated from individuals participating in our epidemiological studies were used for preparation of M antigen. These were chosen for their ability to produce large quantities of M protein as determined by capillary precipitin reaction (15) . M types 1, 4, 5, 6, 9, and 12 ate the subject of this report. A 5-ml amount of a rapidly growing 4-to 6-hr seed culture was inoculated into 1-liter portions of Todd-Hewitt broth (Consolidated Laboratories, Chicago Heights, Ill.). The flasks were incubated for 18 hr at 35 to 37 C, and cells were harvested by centrifugation with a SzentGyorgyi continuous-flow head.
Preparation ofpartially purified type-specific antigen.
The antigen was extracted from the cells by the acidheat method described by Lancefield (4) . The cells were extracted twice and, when both fractions showed activity, they were pooled before the purification procedure.
Semipurified M antigens were prepared from the crude extract by a modification of the method described by Lancefield and Perlmann (7). After ribonuclease treatment, protein was precipitated by increasing concentrations of ammonium sulfate. The most reactive material was precipitated at between 30 and 70%0 saturated (NH4)2SO4, depending on the M type.
Each fraction was dialyzed against borate buffer (pH 7.8 to 8.0) until all (NH4)2SO4 had been removed. Total nitrogen was then determined colorimetrically by a modified micro-Kjeldahl procedure (9) . Each fraction was tested for presence of M protein by the hemagglutination method. The optimal range of antigen concentration which gives maximal sensitivity was determined by titration against adsorbed homologous rabbit antiserum (obtained from the National Communicable Disease Center, Atlanta Ga.). Once this range is selected, further adjustment of antigen concentration will result in optimal specificity as determined by titration against a battery of heterologous rabbit antisera. Those fractions not yielding the desired level of sensitivity and specificity are discarded. Controls. Before the hemagglutination procedure was set up with unknown sera, the sensitized cells were tested-with sera of known hemagglutination titers.
Evidence that the system is working satisfactorily can be determined after 1 hr of incubation at room temperature.
The testing of unknown sera was accompanied by two sets of controls with known sera. One control was set up immediately before the unknown sera were titrated and one immediately after, to check the performance of the reagents throughout the entire procedure. The results in the two sets of controls must agree within one well of the known titer for the tests on the unknown sera to be regarded as reliable.
Hemagglutination inhibition test. The inhbitors used in the hemagglutination inhibition tests were the same semipurified M antigens used for sensitizing RBC. The inhibiting dropping solution (0.025 ml per well) contained approximately 30 pg of antigen per ml to insure maximal inhibition of high-titer homologous rabbit antiserum. After addition of the inhibitor to the test serum, the plates were agitated gently and incubated at room temperature for 30 min before the sensitized RBC were added.
Bactericidal test. The method used in this test was similar to that previously described by Lancefield (5 
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The sensitivity and specificity of our procedure for measurement of type-specific streptococcal antibody (TSA, type-specific antibody, as determined by the hemagglutination procedure described in this report) was maintained at a high tion of type-specific rabbit antiserum with the homologous semipurified antigen preparation blocked the specific antigen-antibody reaction (Table 3) .
Since the bactericidal test is considered to be the most reliable measure of type-specific antibody, we wished to determine the correlation of TSA with bactericidal activity. Figure 1 contains data relating these antibody responses in 293 patients. Coefficients of correlation were calculated between TSA titer and corresponding bactericidal index and were found to be highly significant (P < 0.001). Most observations fell within two standard deviations of the regression line. In general, sera with TSA titers of >160 showed bactericidal activity against the homologous serotype.
TSA response in chimpanzees after induced infection with group A type 12 is shown in Fig. 2 and 3. TSA began to develop at approximately 2 weeks after onset, as does antistreptolysin 0 and antihyaluronidase. However, maximal titers were reached at varying times after onset, depending upon the individual. Detectable antibodies to types 1, 4, 5, and 6 did not develop during the course ofthese experiments.
Some typical responses in patients after known naturally occurring infections by various group A serotypes are given in Table 4 . Homologous TSA titers developed, whereas heterologous response was absent. The specificity of the TSA titer is also -demnonstrated by specific blocking of homologus antigenantibody reaction after adsorption of test sera with appropriate antigen. The significant correla--tion of TSA titer with homologous bactericidal activity is another determinant of such specificity.
We performed thousands of TSA titrations for types 1, 4, 5, 6, 9, and 12 in our laboratory during the past year. These determinations were made on sera collected from individuals participating in our longitudinal studies as well as clinical specimens obtained during epidemic investigations. Clinical and bacteriological data are available on these persons for periods up to 5 years. Of these patients, 84% developed homologous TSA titers of >160 after acquisition of known group A serotypes. Induced infections in our studies with chimpanzees elicited similar specific-antibody response.
Therefore, we suggest that this method of TSA measurement can be used to illuminate an individual's previous streptococcal experience even in the absence of bacteriological data.
Since manipulation of the test sera beyond adsorption with sheep RBC is unnecessary, this procedure provides a practical means of titration of streptococcal TSA on the sera of large numbers of patients, by using minimal quantities of serum and reagents and providing sensitive, specific, reliable, and reproducible results.
